A Phase II Trial of Clofarabine in Older Patients With Acute Myeloid Leukemia for Whom Intensive Chemotherapy is Not Considered Suitable.

Trial Profile

A Phase II Trial of Clofarabine in Older Patients With Acute Myeloid Leukemia for Whom Intensive Chemotherapy is Not Considered Suitable.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Apr 2015

At a glance

  • Drugs Clofarabine (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Sponsors Bioenvision
  • Most Recent Events

    • 14 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jun 2009 Actual initiation date (Jun 2004) added, patient numbers amended from 66 to 69, Genzyme Corporation added as affiliate and sponsor, additional locations, additional primary endpoint as overall response rate as reported by ClinicalTrials.gov.
    • 20 Jun 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top